Flow Cytometry Laboratory Shared Resource
流式细胞术实验室共享资源
基本信息
- 批准号:9923018
- 负责人:
- 金额:$ 12.87万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:Advisory CommitteesBiological AssayBiometryCancer CenterCancer Center Support GrantCell SeparationCellsComprehensive Cancer CenterComputer HardwareComputer softwareConsultConsultationsCustomCytometryDataData AnalysesData SetEducationEducational workshopEnsureEtiologyFacultyFeedbackFlow CytometryFluorescenceFundingFutureGenerationsImage CytometryInformaticsKnowledgeLaboratoriesLaboratory PersonnelMalignant NeoplasmsMissionMonitorNCI Center for Cancer ResearchPopulationPreventionProceduresReagentReproducibilityResearchResearch SupportResource SharingScheduleServicesSorting - Cell MovementStrategic PlanningTechnologyTrainingUniversitiesVendorWisconsinbasecancer therapycomplex data costcost effectivedata acquisitiondesignexperimental studyfluorophoreinformatics shared resourceinstrumentinstrumentationknowledge basememberoperationprogramssuccess
项目摘要
PROJECT SUMMARY / ABSTRACT
The Flow Cytometry Laboratory (FLOW) was established by the UWCCC in 1988 to provide state-of-the-art
instrumentation and expertise that enables our members to acquire and analyze complex data sets on single
cells and cell populations and to isolate defined cell populations for further study.
In the current CCSG funding
cycle, FLOW has supported the research of 137 unique UWCCC members representing all 6 of our scientific
programs.
We have acquired new instrumentation, increased our capacity, established new services, and
expanded our educational programs directed to UWCCC members, their trainees, and staff. We have engaged
UWCCC leaders and our Scientific Advisory Committee to develop a strategic plan that will enable us to
continue to excel in our mission and meet the rapidly evolving research needs of UWCCC members. Over the
course of the next funding cycle we will achieve the following aims. Specific Aim 1 is to provide UWCCC
members access to state-of-the-art instrumentation for single cell analytics and sorting. FLOW houses,
operates, and maintains the broad assortment of instruments required for multi-parameter analytical cytometry,
imaging cytometry, and cell sorting. FLOW has established Standard Operating Procedures (SOPs) that
ensure all instruments are properly calibrated and operated in the manner required to yield high quality
datasets that achieve accepted standards for experimental rigor and reproducibility. Specific Aim 2 is to
provide expertise required for acquisition and analysis of multi-parameter flow cytometry data. Cell analytics
and sorting technologies are advancing rapidly, and FLOW leaders monitor these advances and strive to
ensure UWCCC members are able to fully exploit the newest technologies in their research. FLOW staff are
experts in developing reagent panels that enable members to utilize our instruments to collect multi-parameter
datasets with minimal spectral overlap. In addition, FLOW is developing a collaborative initiative with our
Biostatistics and Cancer Informatics Shared Resources to ensure that the multi-parameter datasets generated
on our instruments have appropriate power for robust statistical and informatics analyses. Specific Aim 3 is to
provide expert consultation and education services that enable our users to take full advantage of our
capabilities in single cell analytics and cell sorting. FLOW staff members consult with users to help them
optimize assay design, data acquisition, data analysis, and data presentation. We provide guidance on
instrument selection and operation. We inform users on incorporating appropriate technical controls into their
experiments. FLOW offers regularly scheduled didactic courses and hands-on training to our users to advance
their knowledge of flow cytometry and enhance their ability to perform high quality research at the lowest
possible cost. FLOW organizes seminars, workshops, and vendor presentations that expand the knowledge
base of our users. Support from the CCSG will enable us to continue to provide high level, cost-effective
services to UWCCC members and thereby advance the UWCCC research mission.
项目总结/摘要
UWCCC于1988年建立了流式细胞术实验室(FLOW),
仪器和专业知识,使我们的成员能够获取和分析复杂的数据集上的一个
细胞和细胞群,并分离确定的细胞群用于进一步研究。
在目前的CCSG资金中,
FLOW已经支持了137个独特的UWCCC成员的研究,这些成员代表了我们所有的6个科学
程序.
我们已经购买了新的仪器,增加了我们的能力,建立了新的服务,
扩大了我们针对UWCCC成员、学员和工作人员的教育计划。我们已聘请
UWCCC领导人和我们的科学咨询委员会制定了一项战略计划,使我们能够
继续在我们的使命中脱颖而出,并满足UWCCC成员快速发展的研究需求。来
在下一个资助周期,我们会达致以下目标。具体目标1是提供UWCCC
会员可以使用最先进的仪器进行单细胞分析和分选。流动房屋,
操作和维护多参数分析细胞仪所需的各种仪器,
成像细胞术和细胞分选。FLOW建立了标准操作程序(SOP),
确保所有仪器都经过正确校准,并以高质量的方式操作
数据集达到实验严格性和可重复性的公认标准。具体目标二是
提供获取和分析多参数流式细胞术数据所需的专业知识。细胞分析
和分类技术正在迅速发展,FLOW领导者监控这些进步,并努力
确保UWCCC成员能够在他们的研究中充分利用最新技术。FLOW工作人员
开发试剂板的专家,使会员能够利用我们的仪器收集多参数
光谱重叠最小的数据集。此外,FLOW正在与我们的
生物统计学和癌症信息学共享资源,以确保生成的多参数数据集
我们的仪器具有适当的能力,可进行强大的统计和信息学分析。具体目标3是
提供专家咨询和教育服务,使我们的用户能够充分利用我们的
单细胞分析和细胞分选的能力。FLOW的工作人员与用户协商,帮助他们
优化分析设计、数据采集、数据分析和数据呈现。我们提供指导,
仪器选择和操作。我们告知用户将适当的技术控制纳入其
实验FLOW为我们的用户提供定期的教学课程和实践培训,
他们的流式细胞术的知识,并提高他们的能力,以最低的执行高质量的研究
可能的成本。FLOW组织研讨会、研讨会和供应商演示,以扩展知识
我们的用户基础。CCSG的支持将使我们能够继续提供高水平、具有成本效益的
为UWCCC成员提供服务,从而推进UWCCC的研究使命。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Manish S Patankar其他文献
Manish S Patankar的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Manish S Patankar', 18)}}的其他基金
Using a chemical biology approach to develop novel inhibitors of mitochondrial oxidative phosphorylation for the treatment of ovarian cancer
使用化学生物学方法开发用于治疗卵巢癌的新型线粒体氧化磷酸化抑制剂
- 批准号:
10260915 - 财政年份:2022
- 资助金额:
$ 12.87万 - 项目类别:
Using a chemical biology approach to develop novel inhibitors of mitochondrial oxidative phosphorylation for the treatment of ovarian cancer
使用化学生物学方法开发用于治疗卵巢癌的新型线粒体氧化磷酸化抑制剂
- 批准号:
10513296 - 财政年份:2022
- 资助金额:
$ 12.87万 - 项目类别:
Developing non-human primate models for ovarian cancer
开发卵巢癌的非人类灵长类动物模型
- 批准号:
10044729 - 财政年份:2020
- 资助金额:
$ 12.87万 - 项目类别:
Ovarian cancer diagnosis by monitoring immune cell bound MUC16 (CA125)
通过监测免疫细胞结合 MUC16 (CA125) 诊断卵巢癌
- 批准号:
8123435 - 财政年份:2010
- 资助金额:
$ 12.87万 - 项目类别:
相似海外基金
Establishment of a new biological assay using Hydra nematocyst deployment
利用水螅刺丝囊部署建立新的生物测定方法
- 批准号:
520728-2017 - 财政年份:2017
- 资助金额:
$ 12.87万 - 项目类别:
University Undergraduate Student Research Awards
POINT-OF-CARE BIOLOGICAL ASSAY FOR DETERMINING TISSUE-SPECIFIC ABSORBED IONIZING RADIATION DOSE (BIODOSIMETER) AFTER RADIOLOGICAL AND NUCLEAR EVENTS.
用于确定放射和核事件后组织特异性吸收电离辐射剂量(生物剂量计)的护理点生物测定。
- 批准号:
10368760 - 财政年份:2017
- 资助金额:
$ 12.87万 - 项目类别:
POINT-OF-CARE BIOLOGICAL ASSAY FOR DETERMINING TISSUE-SPECIFIC ABSORBED IONIZING RADIATION DOSE (BIODOSIMETER) AFTER RADIOLOGICAL AND NUCLEAR EVENTS.
用于确定放射和核事件后组织特异性吸收电离辐射剂量(生物剂量计)的护理点生物测定。
- 批准号:
10669539 - 财政年份:2017
- 资助金额:
$ 12.87万 - 项目类别:
POINT-OF-CARE BIOLOGICAL ASSAY FOR DETERMINING TISSUE-SPECIFIC ABSORBED IONIZING RADIATION DOSE (BIODOSIMETER) AFTER RADIOLOGICAL AND NUCLEAR EVENTS.
用于确定放射和核事件后组织特异性吸收电离辐射剂量(生物剂量计)的护理点生物测定。
- 批准号:
9570142 - 财政年份:2017
- 资助金额:
$ 12.87万 - 项目类别:
POINT-OF-CARE BIOLOGICAL ASSAY FOR DETERMINING TISSUE-SPECIFIC ABSORBED IONIZING RADIATION DOSE (BIODOSIMETER) AFTER RADIOLOGICAL AND NUCLEAR EVENTS.
用于确定放射和核事件后组织特异性吸收电离辐射剂量(生物剂量计)的护理点生物测定。
- 批准号:
9915803 - 财政年份:2017
- 资助金额:
$ 12.87万 - 项目类别:
COVID-19 Supplemental work: POINT-OF-CARE BIOLOGICAL ASSAY FOR DETERMINING TISSUE-SPECIFIC ABSORBED IONIZING RADIATION DOSE (BIODOSIMETER).
COVID-19 补充工作:用于确定组织特异性吸收电离辐射剂量的护理点生物测定(生物剂量计)。
- 批准号:
10259999 - 财政年份:2017
- 资助金额:
$ 12.87万 - 项目类别:
Drug discovery based on a new biological assay system using Yeast knock-out strain collection
基于使用酵母敲除菌株收集的新生物测定系统的药物发现
- 批准号:
21580130 - 财政年份:2009
- 资助金额:
$ 12.87万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Machine learning for automatic gene annotation using high-throughput biological assay data
使用高通量生物测定数据进行自动基因注释的机器学习
- 批准号:
300985-2004 - 财政年份:2005
- 资助金额:
$ 12.87万 - 项目类别:
Postdoctoral Fellowships
Machine learning for automatic gene annotation using high-throughput biological assay data
使用高通量生物测定数据进行自动基因注释的机器学习
- 批准号:
300985-2004 - 财政年份:2004
- 资助金额:
$ 12.87万 - 项目类别:
Postdoctoral Fellowships














{{item.name}}会员




